UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837–853 (1998).
UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352, 854–865 (1998).
Ohkubo, Y. et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res. Clin. Pract. 28, 103–117 (1995).
Google Scholar
Fang, M., Wang, D., Coresh, J. & Selvin, E. Trends in diabetes treatment and control in US adults, 1999–2018. N. Engl. J. Med. 384, 2219–2228 (2021).
Google Scholar
Evert, A. B. et al. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care 42, 731–754 (2019).
Google Scholar
ElSayed, N. A. et al. Facilitating positive health behaviors and well-being to improve health outcomes: standards of care in diabetes—2025. Diabetes Care 48, S86–S127 (2025).
Appel, L. J. et al. A clinical trial of the effects of dietary patterns on blood pressure. N. Engl. J. Med. 336, 1117–1124 (1997).
Google Scholar
Sacks, F. M. et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N. Engl. J. Med. 344, 3–10 (2001).
Google Scholar
Appel, L. J. et al. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 294, 2455–2464 (2005).
Google Scholar
Arnett, D. K. et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 74, e177–e232 (2019).
Google Scholar
McEvoy, J. W. et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension: developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO). Eur. Heart J. 45, 3912–4018 (2024).
Google Scholar
Cheung, A. K. et al. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 99, S1–S87 (2021).
Akhlaghi, M. Dietary Approaches to Stop Hypertension (DASH): potential mechanisms of action against risk factors of the metabolic syndrome. Nutr. Res. Rev. 33, 1–18 (2020).
Google Scholar
Glenn, A. J. et al. Longitudinal changes in adherence to the portfolio and DASH dietary patterns and cardiometabolic risk factors in the PREDIMED-Plus study. Clin. Nutr. 40, 2825–2836 (2021).
Google Scholar
Paula, T. P. et al. Effects of the DASH diet and walking on blood pressure in patients with type 2 diabetes and uncontrolled hypertension: a randomized controlled trial. J. Clin. Hypertens. 17, 895–901 (2015).
Azadbakht, L. et al. Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial. Diabetes Care 34, 55–57 (2011).
Google Scholar
Jannasch, F., Kröger, J. & Schulze, M. B. Dietary patterns and type 2 diabetes: a systematic literature review and meta-analysis of prospective studies. J. Nutr. 147, 1174–1182 (2017).
Google Scholar
Chiavaroli, L. et al. DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses. Nutrients 11, 338 (2019).
Google Scholar
ElSayed, N. A. et al. 7. Diabetes technology: standards of care in diabetes—2024. Diabetes Care 47, S126–S144 (2024).
Ceriello, A., Monnier, L. & Owens, D. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol. 7, 221–230 (2019).
Google Scholar
Gilliam, L. K., Parker, M. M., Moffet, H. H., Lee, A. K. & Karter, A. J. Continuous glucose monitor metrics are associated with emergency department visits and hospitalizations for hypoglycemia and hyperglycemia, but have low predictive value. Diabetes Technol. Ther. 26, 298–306 (2024).
Google Scholar
Lu, J. et al. Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: a prospective cohort study. Diabetes Care 44, 549–555 (2021).
Google Scholar
Raj, R. et al. Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review. BMJ Open Diabetes Res. Care 10, e002573 (2022).
Google Scholar
Pilla, S. J. et al. Dietary patterns, sodium reduction, and blood pressure in type 2 diabetes: The DASH4D Randomized Clinical Trial. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2025.1580 (2025).
Goff, H. D., Repin, N., Fabek, H., El Khoury, D. & Gidley, M. J. Dietary fibre for glycaemia control: towards a mechanistic understanding. Bioact. Carbohydr. Diet. Fibre 14, 39–53 (2018).
Google Scholar
Silva, F. M. et al. Fiber intake and glycemic control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials. Nutr. Rev. 71, 790–801 (2013).
Google Scholar
Mao, T., Huang, F., Zhu, X., Wei, D. & Chen, L. Effects of dietary fiber on glycemic control and insulin sensitivity in patients with type 2 diabetes: a systematic review and meta-analysis. J. Funct. Foods 82, 104500 (2021).
Google Scholar
Reynolds, A. N., Akerman, A. P. & Mann, J. Dietary fibre and whole grains in diabetes management: systematic review and meta-analyses. PLoS Med. 17, e1003053 (2020).
Google Scholar
Reynolds, A. et al. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet 393, 434–445 (2019).
Google Scholar
Åberg, S., Mann, J., Neumann, S., Ross, A. B. & Reynolds, A. N. Whole-grain processing and glycemic control in type 2 diabetes: a randomized crossover trial. Diabetes Care 43, 1717–1723 (2020).
Google Scholar
Battelino, T. et al. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 11, 42–57 (2023).
Google Scholar
Beck, R. W. et al. Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care 42, 400–405 (2019).
Google Scholar
Vigersky, R. A. & McMahon, C. The relationship of hemoglobin A1C to time-in-range in patients with diabetes. Diabetes Technol. Ther. 21, 81–85 (2019).
Google Scholar
Harnden, K., Frayn, K. & Hodson, L. Dietary Approaches to Stop Hypertension (DASH) diet: applicability and acceptability to a UK population. J. Hum. Nutr. Diet. 23, 3–10 (2010).
Google Scholar
Baker, E. A., Barnidge, E. K., Schootman, M., Sawicki, M. & Motton-Kershaw, F. L. Adaptation of a modified DASH diet to a rural African American community setting. Am. J. Prev. Med. 51, 967–974 (2016).
Google Scholar
Kim, H., Song, H.-J., Han, H.-R., Kim, K. B. & Kim, M. T. Translation and validation of the dietary approaches to stop hypertension for Koreans intervention: culturally tailored dietary guidelines for Korean Americans with high blood pressure. J. Cardiovasc. Nurs. 28, 514–523 (2013).
Google Scholar
Filippou, C. D. et al. Dietary Approaches to Stop Hypertension (DASH) diet and blood pressure reduction in adults with and without hypertension: a systematic review and meta-analysis of randomized controlled trials. Adv. Nutr. 11, 1150–1160 (2020).
Google Scholar
Theodoridis, X. et al. Adherence to the DASH diet and risk of hypertension: a systematic review and meta-analysis. Nutrients 15, 3261 (2023).
Google Scholar
Whitt-Glover, M. C. et al. Translating the Dietary Approaches to Stop Hypertension (DASH) diet for use in underresourced, urban African American communities, 2010. Prev. Chronic Dis. 10, 120088 (2013).
Google Scholar
FreeStyle Libre Pro Flash Glucose Monitoring System. US Food and Drug Administration www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P150021 (2016).
FreeStyle Libre 3 Continuous Glucose Monitoring System. 510(k) substantial equivalence determination decision summary. US Food and Drug Administration www.accessdata.fda.gov/cdrh_docs/reviews/K212132.pdf (2022).
Li, G. et al. Exploring ethnic representativeness in diabetes clinical trial enrolment from 2000 to 2020: a chronological survey. Diabetologia 65, 1461–1472 (2022).
Google Scholar
Dietary Approaches to Stop Hypertension for Diabetes (DASH4D). ClinicalTrials.gov https://clinicaltrials.gov/study/NCT04286555?a=12 (2024).
Wang, D. et al. Design of the continuous glucose monitoring (CGM) study in the Dietary Approaches to Stop Hypertension for Diabetes Trial (DASH4D-CGM). Contemp. Clin. Trials 151, 107845 (2025).
Google Scholar
ElSayed, N. A. et al. 5. Facilitating positive health behaviors and well-being to improve health outcomes: standards of care in diabetes—2024. Diabetes Care 47, S77–S110 (2024).
National Academies of Sciences Engineering and Medicine. Dietary Reference Intakes for Sodium and Potassium (National Academies Press, 2019); https://doi.org/10.17226/25353
Nutritional Intakes from Food and Beverages: Mean Amounts Consumed per Individual, by Gender and Age. What We Eat in America, NHANES 2013–2014 (US Department of Agriculture, 2016); www.ars.usda.gov/arsuserfiles/80400530/pdf/1314/table_1_nin_gen_13.pdf
Nutritional Intakes from Food and Beverages: Mean Amounts Consumed per Individual, by Gender and Age. What We Eat in America, NHANES 2015–2016 (US Department of Agriculture, 2018); https://www.ars.usda.gov/arsuserfiles/80400530/pdf/1516/table_1_nin_gen_15.pdf
McClure, S. T. et al. Dietary intake of adults with and without diabetes: results from NHANES 2013–2016. BMJ Open Diabetes Res. Care 8, e001681 (2020).
Google Scholar
Whelton, P. K. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 71, e127–e248 (2018).
Google Scholar
Abbott. About Freestyle Libre Pro. Vol. 2024 (2023); https://www.freestyle.abbott/in-en/libre-pro.html
ElSayed, N. A. et al. Glycemic goals and hypoglycemia: standards of care in diabetes—2024. Diabetes Care 47, S111–S125 (2024).
Battelino, T. et al. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.Lancet Diabetes Endocrinol. 11, 42–57 (2023).
Google Scholar
Bergenstal, R. M. et al. Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. Diabetes Care 41, 2275–2280 (2018).
Google Scholar
Klonoff, D. C. et al. A glycemia risk index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings. J. Diabetes Sci. Technol. 17, 1226–1242 (2023).
Google Scholar
Patel, S. M. et al. Dietary sodium reduction does not affect circulating glucose concentrations in fasting children or adults: findings from a systematic review and meta-analysis. J. Nutr. 145, 505–513 (2015).
Google Scholar
Brown, S. A. et al. Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N. Engl. J. Med. 381, 1707–1717 (2019).
Google Scholar
Ware, J. et al. Randomized trial of closed-loop control in very young children with type 1 diabetes. N. Engl. J. Med. 386, 209–219 (2022).
Google Scholar
Russell, S. J. et al. Multicenter, randomized trial of a bionic pancreas in type 1 diabetes. N. Engl. J. Med. 387, 1161–1172 (2022).
Google Scholar
